Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.98 USD | +5.89% | +9.50% | -24.62% |
Mar. 26 | Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Tucker
CEO | Chief Executive Officer | 55 | 21-09-15 |
Kevin Coveney
DFI | Director of Finance/CFO | 60 | 23-03-12 |
Jillian Hagel
CTO | Chief Tech/Sci/R&D Officer | 45 | 21-09-15 |
Peter Facchini
PRN | Corporate Officer/Principal | 60 | 21-09-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Webb
CHM | Chairman | 66 | 22-06-12 |
Joseph Tucker
CEO | Chief Executive Officer | 55 | 21-09-15 |
Frank Pasqualone
BRD | Director/Board Member | 68 | 22-07-12 |
George Kegler
BRD | Director/Board Member | 68 | 20-12-29 |
Director/Board Member | 60 | 21-01-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,294,005 | 7,030,852 ( 96.39 %) | 0 | 96.39 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.62% | 7.15M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ENVB Stock
- Company Enveric Biosciences, Inc.